A study found that for patients with early-stage cervical cancer without high-risk factors, postoperative radiotherapy (RT) alone produces similar outcomes to concurrent chemoradiotherapy, regardless of histological subtype. Chemoradiotherapy led to more grade 3 or higher hematological toxicities. Among intermediate-risk patients, 5-year overall survival and disease-free survival rates were similar with RT alone and chemoradiotherapy. For low-risk patients, 5-year overall survival was higher with RT, while disease-free survival was similar between the two groups. Chemoradiotherapy patients experienced more acute hematological toxicities. The study was retrospective and some patients received neoadjuvant chemotherapy, potentially affecting treatment outcomes.
Source link
Chemoradiotherapy or RT in Lower Risk Early Cervical Cancer?
